Psychlomere | Clinical Trial Endpoints for CNS & Rare Disease
Clinical psychologists and subject matter experts (SME) consulting on clinical development, clinical operations, pilot and post approval studies, and regulatory support to design and develop fit‑for‑purpose clincial outcomes assessments (COAs), endpoints, and biomarkers to accelerate clinical trials specializing in CNS and rare diseases trials from design to validation.
Overview
Psychlomere, LLC is a consulting company based in Littleton, CO, specializing in clinical trial endpoints for central nervous system (CNS) and rare disease studies. The company provides expertise in clinical development, clinical operations, and regulatory support to design and develop clinical outcomes assessments (COAs), endpoints, and biomarkers. Psychlomere's team includes clinical psychologists trained in clinical study design and psychometric development, utilizing the Psychlomere Framework to create trial-ready endpoints. Their services aim to enhance clinical trial design and ensure meaningful endpoints, facilitating the acceleration of clinical trials from design to validation.
Details
- Category
- Business Consulting and Services
- Headquarters
- Littleton, CO
- Type
- Self-Owned
- Followers
- 427
- Specialties
- Clinical Development, Clinical Operations, Externally Sponsored Studies, Regulatory & Advisory Board, Clinical Trials, Endpoint Solutions, Rare Disease, CNS Disorders, Biomarkers, EEG, fMRI, Eye-tracking, and Clinical Psychology
- Locations
- Littleton, CO 80123, US